Page last updated: 2024-09-03
eriodictyol 7-glucuronide and eriocitrin
eriodictyol 7-glucuronide has been researched along with eriocitrin in 1 studies
*eriocitrin: structure in first source [MeSH]
*eriocitrin: structure in first source [MeSH]
Compound Research Comparison
Studies (eriodictyol 7-glucuronide) | Trials (eriodictyol 7-glucuronide) | Recent Studies (post-2010) (eriodictyol 7-glucuronide) | Studies (eriocitrin) | Trials (eriocitrin) | Recent Studies (post-2010) (eriocitrin) |
---|---|---|---|---|---|
6 | 0 | 3 | 41 | 1 | 32 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chandra, S; Gangadhariah, M; Pardhi, T; Ravilla, J; Singh, SA | 1 |
Other Studies
1 other study(ies) available for eriodictyol 7-glucuronide and eriocitrin
Article | Year |
---|---|
Citrus nutraceutical eriocitrin and its metabolites are partial agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a molecular docking and molecular dynamics study.
Topics: Citrus; Diabetes Mellitus, Type 2; Dietary Supplements; Flavonoids; Glucuronides; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; PPAR gamma | 2023 |